The current state of microbial proteomics: Where we are and where we want to go

被引:10
|
作者
Chao, Tzu-Chiao [2 ]
Hansmeier, Nicole [1 ]
机构
[1] Arizona State Univ, Biodesign Inst, Swette Ctr Environm Biotechnol, Tempe, AZ 85287 USA
[2] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA
关键词
Absolute quantification; Constraint-based model; Microbiology; MS; Networks; Single cell; DIFFERENCE GEL-ELECTROPHORESIS; ASSISTED-LASER-DESORPTION/IONIZATION; PATHOGEN LEPTOSPIRA-INTERROGANS; SCALE METABOLIC RECONSTRUCTIONS; IONIZATION-MASS-SPECTROMETRY; ESCHERICHIA-COLI PROTEOME; FLUX BALANCE ANALYSIS; SINGLE-CELL ANALYSIS; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS;
D O I
10.1002/pmic.201100381
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteomics allows the assessment of cellular processes in an unprecedented scale by providing a comprehensive quantitative and qualitative overview of the protein content of a cell. Consequently, proteomics has been employed to investigate a multitude of bacterial processes ranging from the analysis of environmental communities, identification of virulence factors to the proteome-guided optimization of production strains. Proteomics has, in short, become an indispensable tool for the global analysis of bacterial physiology. Nonetheless, challenges exist, especially in the accurate prediction of phenotypic consequences based on any given proteome composition. In this review, we will give an overview of current highlights in the area of microbial proteomics, discuss some current challenges and present new developments that may help in overcoming them.
引用
收藏
页码:638 / 650
页数:13
相关论文
共 50 条
  • [41] Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?
    More, Sonia
    Corvatta, Laura
    Manieri, Valentina Maria
    Saraceni, Francesco
    Scortechini, Ilaria
    Mancini, Giorgia
    Fiorentini, Alessandro
    Olivieri, Attilio
    Offidani, Massimo
    CELLS, 2022, 11 (04)
  • [42] CardioMEMS: where we are and where can we go?
    Pour-Ghaz, Issa
    Hana, David
    Raja, Joel
    Ibebuogu, Uzoma N.
    Khouzam, Raini
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [43] TAKEOVERS - WHERE ARE WE - WHERE DO WE GO
    SUBAK, JT
    BUSINESS LAWYER, 1986, 41 (04): : 1255 - 1264
  • [44] The Holocaust -: Where we are, where we need to go
    Jäckel, E
    HOLOCAUST AND HISTORY: THE KNOWN, THE UNKNOWN, THE DISPUTED, AND THE REEXAMINED, 1998, : 23 - 29
  • [45] Digital Radiation Oncology (4.0?) - where do we stand, where do we want to go?
    Heinemann, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S113 - S113
  • [46] Epidemiology of measles in Bavaria. Where do we stand, where do we want to go
    Schoenberger, K.
    Sing, A.
    Wildner, M.
    Liebl, B.
    Hautmann, W.
    GESUNDHEITSWESEN, 2015, 77
  • [47] Anticoagulation: where we are and where we need to go
    Barnes, Geoffrey D.
    Froehlich, James B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 220 - 223
  • [48] LOUISIANA - WHERE WE ARE AND WHERE WE HOPE TO GO
    DURBIN, GJ
    SUGAR JOURNAL, 1978, 40 (10): : 8 - 8
  • [49] GRAVITATIONAL WAVES: WHERE WE ARE, WHERE WE GO
    Ricci, Fulvio
    7TH ROMA INTERNATIONAL CONFERENCE ON ASTROPARTICLE PHYSICS (RICAP18), 2019, 209
  • [50] Synucleinopathies: Where we are and where we need to go
    Bras, Ines Caldeira
    Dominguez-Meijide, Antonio
    Gerhardt, Ellen
    Koss, David
    Lazaro, Diana F.
    Santos, Patricia, I
    Vasili, Eftychia
    Xylaki, Mary
    Outeiro, Tiago Fleming
    JOURNAL OF NEUROCHEMISTRY, 2020, 153 (04) : 433 - 454